First Command Advisory Services’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

First Command Advisory Services’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$360	Buy	+12	New	+$341	﹤0.01%	1201

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

DCM

DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

First Command Advisory Services's LKFT Position: Q2 2026 in Review

First Command Advisory Services opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 12 shares worth $360. The stake represents ﹤0.01% of the portfolio and ranks #1201 among its holdings.

77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

First Command Advisory Services held 12 shares of Lakefront Biotherapeutics American Depositary Shares worth $360 as of Q2 2026.
Lakefront Biotherapeutics American Depositary Shares was a new First Command Advisory Services position in Q2 2026.
Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of First Command Advisory Services's portfolio in Q2 2026, its #1201 holding.
77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on First Command Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.